ArticleCritical care (London, England)2026
Critical illness at extreme age: outcomes and clinical characteristics of centenarian ICU admissions in Australia and New Zealand.
Article in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Much of the excess mortality in immunocompromised patients with viral severe acute respiratory infection occurs after ICU discharge.Critical care (London, England) · 2026Article
- Aspiration pneumonia in the world's most aged society: age-stratified ICU management and outcomes from a nationwide Japanese registry.Journal of intensive care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe centenarian population is increasing globally, yet data describing intensive care unit (ICU) outcomes in this age group remain limited. We aimed to describe the clinical characteristics and outcomes of centenarians admitted to ICU and to evaluate the performance of commonly used severity-of-illness scores for mortality prediction.
methodsThis retrospective cohort study included all index ICU admissions of patients aged ≥100 years recorded in the Australian and New Zealand Intensive Care Society Adult Patient Database between 2010 and 2024. The primary outcome was in-hospital mortality. Secondary outcomes included ICU mortality, discharge destination, and survival at 6 months, 1 year, and 2 years. Competing-risk regression was used to assess factors associated with mortality. Discrimination of SOFA, APACHE III, and ANZROD was evaluated using the area under the receiver operating characteristic curve (AUROC).
resultsAmong 460 centenarians, the median age was 100.9 years (IQR 100.3–102.0), and 67.2% were female. Surgical admissions predominated (67.2%). Treatment limitation orders were documented in 33.9% of patients, whereas invasive mechanical ventilation was used in 10.3%. In-hospital mortality was 13.7%, and ICU mortality was 3.9%, with most deaths occurring early during hospitalisation. Among hospital survivors, 54.1% were discharged home, with a median post-discharge survival of 21.9 months. Acute illness severity was strongly associated with mortality in adjusted competing-risk models, whereas chronological age was not. ANZROD demonstrated superior discrimination for ICU mortality (AUROC 0.90) and hospital mortality (AUROC 0.82) compared with SOFA and APACHE III.
conclusionIn this binational cohort, ICU admission among centenarians was infrequent and occurred in a highly selected population. Treatment limitation orders were common and mechanical ventilation was uncommon; approximately half of hospital survivors were discharged directly home. In-hospital mortality was relatively low and more strongly associated with acute illness severity than with chronological age. These findings support individualised clinical decision-making regarding ICU admission at extreme age rather than age-based exclusion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.